BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Graudal N, Leth P, Mårbjerg L, Galløe AM. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies. J Intern Med 1991;230:165-71. [PMID: 1650808 DOI: 10.1111/j.1365-2796.1991.tb00425.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Nagappa B, Ramalingam A, Rastogi A, Dubey S, Thomas SS, Gupta E, Sarin SK. Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi. J Family Med Prim Care 2021;10:1412-8. [PMID: 34041187 DOI: 10.4103/jfmpc.jfmpc_1441_20] [Reference Citation Analysis]
2 Nilsson E, Anderson H, Sargenti K, Lindgren S, Prytz H. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year population-based study. Aliment Pharmacol Ther. 2016;43:1330-1339. [PMID: 27091240 DOI: 10.1111/apt.13635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
3 Tarapure S, Tubaki BR, Khot S. Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) - A single arm clinical trial. J Ayurveda Integr Med 2021;12:136-42. [PMID: 33579578 DOI: 10.1016/j.jaim.2020.12.015] [Reference Citation Analysis]
4 Carrier P, Debette-Gratien M, Jacques J, Loustaud-Ratti V. Cirrhotic patients and older people. World J Hepatol 2019;11:663-77. [PMID: 31598192 DOI: 10.4254/wjh.v11.i9.663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Göbel T, Schadewaldt-tümmers J, Greiner L, Poremba C, Häussinger D, Erhardt A. Transient elastography improves detection of liver cirrhosis compared to routine screening tests. WJG 2015;21:953. [DOI: 10.3748/wjg.v21.i3.953] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Bloom S, Kemp W, Nicoll A, Roberts SK, Gow P, Dev A, Bell S, Sood S, Kronborg I, Knight V, Lewis D, Lubel J. Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C. Journal of Hepatology 2018;69:575-83. [DOI: 10.1016/j.jhep.2018.04.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
7 Naqvi IH, Talib A, Mahmood K, Abidi R, Rizvi SNZ. The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics. Prz Gastroenterol 2019;14:250-7. [PMID: 31988671 DOI: 10.5114/pg.2019.83872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Fujimoto K, Sawabe M, Sasaki M, Kino K, Arai T. Undiagnosed cirrhosis occurs frequently in the elderly and requires periodic follow ups and medical treatments. Geriatr Gerontol Int. 2008;8:198-203. [PMID: 18822004 DOI: 10.1111/j.1447-0594.2008.00470.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
9 Del Poggio P, Olmi S, Ciccarese F, Mazzoleni M, Jazzetti M, Jamoletti C, Mattiello M, Del Poggio A, Portugali V, Stroffolini T. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2015;27:1103-8. [PMID: 26049705 DOI: 10.1097/MEG.0000000000000404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
10 Falagas ME, Vardakas KZ, Vergidis PI. Under-diagnosis of common chronic diseases: prevalence and impact on human health: Under-diagnosis of common diseases. International Journal of Clinical Practice 2007;61:1569-79. [DOI: 10.1111/j.1742-1241.2007.01423.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
11 Guss D, Sherigar J, Mohanty SR. Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients. Gastroenterology Res 2018;11:333-9. [PMID: 30344803 DOI: 10.14740/gr1074w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Pantea R, Meister P, Neuhaus JP, Nowak K, Paul A, Saner FH. [Surgery in patients with liver cirrhosis]. Chirurg 2021;92:838-45. [PMID: 33459796 DOI: 10.1007/s00104-020-01319-z] [Reference Citation Analysis]
13 Arya S, Kumar P, Tiwari B, Belwal S, Saxena S, Abbas H. What Every Intensivist should Know about Impairment of Cardiac Function and Arrhythmias in Liver Disease Patients: A Review. Indian J Crit Care Med 2020;24:1251-5. [PMID: 33446981 DOI: 10.5005/jp-journals-10071-23695] [Reference Citation Analysis]
14 Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HLY, Irving WL, Sheridan D, Abate ML, Adams LA, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Nattermann J, Riordan S, Miele L, Kelaeng KS, Ampuero J, Ahlenstiel G, McLeod D, Powell E, Liddle C, Douglas MW, Booth DR, George J; International Liver Disease Genetics Consortium (ILDGC). FibroGENE: A gene-based model for staging liver fibrosis. J Hepatol. 2016;64:390-398. [PMID: 26592354 DOI: 10.1016/j.jhep.2015.11.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
15 Dawood RM, Salum GM, El-Meguid MA, Elsayed A, Yosry A, Abdelaziz A, Shousha HI, Nabeel MM, El Awady MK. Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians. Microb Pathog 2021;153:104805. [PMID: 33609649 DOI: 10.1016/j.micpath.2021.104805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Widhiantara IG, Jawi IM. Phytochemical composition and health properties of Sembung plant (Blumea balsamifera): A review. Vet World 2021;14:1185-96. [PMID: 34220120 DOI: 10.14202/vetworld.2021.1185-1196] [Reference Citation Analysis]
17 Nguyen-khac E. Résultats et place du Fibroscan® dans le diagnostic non invasif de la fibrose hépatique. La Revue de Médecine Interne 2007;28:94-102. [DOI: 10.1016/j.revmed.2006.10.329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
18 Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon 2014;14:e23539. [PMID: 25477978 DOI: 10.5812/hepatmon.23539] [Cited by in Crossref: 58] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
19 Tovoli F, De Lorenzo S, Samolsky Dekel BG, Piscaglia F, Benevento F, Brandi G, Bolondi L. Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma. Liver Int 2018;38:278-84. [PMID: 28792650 DOI: 10.1111/liv.13546] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
20 Gaduputi V, Abdulsamad M, Sakam S, Abbas N, Tariq H, Ihimoyan A. Systemic vascular resistance in cirrhosis: a predictor of severity? Hepat Med 2014;6:95-101. [PMID: 25187743 DOI: 10.2147/HMER.S67036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Nguyen-khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly J, Brevet M, Grignon P, Lion S, Le Page L, Dupas J. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Alimentary Pharmacology & Therapeutics 2008;28:1188-98. [DOI: 10.1111/j.1365-2036.2008.03831.x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 116] [Article Influence: 11.2] [Reference Citation Analysis]
22 Miniati D, Jelin EB, Ng J, Wu J, Carlson TR, Wu X, Looney MR, Wang RA. Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice. Am J Physiol Lung Cell Mol Physiol 2010;298:L169-77. [PMID: 19933399 DOI: 10.1152/ajplung.00188.2009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
23 Gotlieb N, Schwartz N, Zelber-Sagi S, Chodick G, Shalev V, Shibolet O. Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World J Gastroenterol 2020;26:5849-62. [PMID: 33132639 DOI: 10.3748/wjg.v26.i38.5849] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol. 2006;18:1321-1325. [PMID: 17099382 DOI: 10.1097/01.meg.0000243884.55562.37] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
25 Karsan HA, Rojter SE, Saab S. Primary prevention of cirrhosis. Public health strategies that can make a difference. Postgrad Med. 2004;115:25-30. [PMID: 14755873 DOI: 10.3810/pgm.2004.01.1416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
26 Gaba RC, Mendoza-Elias N, Regan DP, Garcia KD, Lokken RP, Schwind RM, Eichner M, Thomas FM, Rund LA, Schook LB, Schachtschneider KM. Characterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic Platform. J Vasc Interv Radiol 2018;29:1194-1202.e1. [PMID: 29887183 DOI: 10.1016/j.jvir.2018.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
27 Aubé C, Winkfield B, Oberti F, Vuillemin E, Rousselet MC, Caron C, Calès P. New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol. 2004;16:743-751. [PMID: 15256975 DOI: 10.1097/01.meg.0000108357.41221.e5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
28 Shen L, Li JQ, Zeng MD, Lu LG, Fan ST, Bao H. Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis. World J Gastroenterol. 2006;12:1292-1295. [PMID: 16534888 DOI: 10.3748/wjg.v12.i8.1292] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
29 de Bruyn G, Graviss EA. A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis. BMC Med Inform Decis Mak 2001;1:6. [PMID: 11806763 DOI: 10.1186/1472-6947-1-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
30 Serin A, Sahin T, Arikan BT, Emek E, Bozkurt B, Tokat Y. A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey. Transplant Proc 2019;51:2416-9. [PMID: 31402253 DOI: 10.1016/j.transproceed.2019.01.190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Mcavoy NC, Hayes PC. The cirrhosis epidemic in the UK: evaluating the causes in a European context. Expert Review of Gastroenterology & Hepatology 2014;1:41-5. [DOI: 10.1586/17474124.1.1.41] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
32 Aubé C, Oberti F, Korali N, Namour M, Loisel D, Tanguy J, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maïga MY, Penneau-fontbonne D, Caron C, Calès P. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. Journal of Hepatology 1999;30:472-8. [DOI: 10.1016/s0168-8278(99)80107-x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]
33 Yates SG, Gavva C, Agrawal D, Sarode R. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?: TRANSFUSION IN CIRRHOSIS. Transfusion 2016;56:791-8. [DOI: 10.1111/trf.13495] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
34 Lim Y, Kim WR. The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease. Clinics in Liver Disease 2008;12:733-46. [DOI: 10.1016/j.cld.2008.07.007] [Cited by in Crossref: 187] [Cited by in F6Publishing: 160] [Article Influence: 14.4] [Reference Citation Analysis]